PYPing Ye

Ping Ye

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Ping Ye has a total of 150 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Association of hepcidin with serum lipids, triglyceride-glucose index, and High-sensitivity cardiac troponin T in Metabolic syndrome population

    by Xiaona Wang, Wenkai Xiao, Li Sheng, Ping Ye

    Background Hepcidin has been viewed as a reliable surrogate of cardiovascular disease (CVD) risk. We investigate the correlation between Hepcidin with serum lipids, triglyceride-glucose index, and High-sensitivity cardiac troponin T (Hs-cTnT) in community-based population by using Hs-cTnT as measuring indicator for myocardial injury. Methods We analyzed the association of baseline Hepcidin with serum lipids, triglyceride-glucose index, and Hs-cTnT levels in 1447 subjects from a community-based population in Beijing, China. Results There were significant differences in age, sex, smoking, SBP, HDL-C, LDL-C, Sd-LDL, PCSK9, LDL-TG, Apo EH, Lp(a), eGFR, hepcidin and Hs-cTnT between populations with or without Mets (P < 0.05). In correlation analysis, hepcidin was correlated with TG (β = 0.663; p = 0.002), sd-LDL (β = 9.893; p = 0.015), PCSK9 (β = 16.385; p < 0.001), RLP-C (β = 8.530; p = 0.011), LDL-TG (β = 4.652; p = 0.006), and TyG (r = 0.246; p < 0.001). Multiple linear regression analysis showed that baseline hepcidin (β = 0.584, 95%CI:0.236–0.932, P = 0.001) was positively correlated with follow-up Hs-cTnT levels in subjects with Mets. Additionally, HDL-C levels were negatively correlated with follow-up Hs-cTnT levels (β=−0.429, 95% CI: -0.791- -0.066, P = 0.021). In subjects with Mets, Logistics regression model showed that hepcidin was associated with elevated Hs-cTnT (HR = 2.534, 95%CI: 1.267–5.357, P < 0.05), but not for non-Mets group. Model 1 showed that high hepcidin was a risk factor for elevated Hs-cTnT independent of hepcidin, TG, Sd-LDL, PCSK-9, RLP-C, LDL-TG, Lp(a) and HDL-C in subjects with Mets (HR = 3.284; 95%CI: 1.015–10.634, P < 0.001). Conclusions Our findings in a Chinese cohort suggest that hepcidin is a risk factor for elevated Hs-cTnT in patients with Mets.

  • Performance of the ABCD-GENE Score for Predicting Clinical Outcomes in Clopidogrel-Treated Patients with ACS

    by Ying Jin, Jing Ma, Ziqian Wang, Yuting Zou, Guanyun Wang, Yangxun Wu, Yuyan Wang, Haiping Liu, Tong Yin, Ping Ye

    The ABCD-GENE score was constructed to identify patients with high platelet reactivity (HPR) after 30 days of clopidogrel treatment. In our study, 1297 eligible patients with acute coronary syndrome (ACS) were included, and 44 (3.4%) major adverse cardiovascular events (MACEs) occurred during the 12-month clopidogrel treatment. The score with a cutoff of ≥ 10 was independently associated with the risk of 5-day HPR (adjusted HR: 1.73, 95% CI: 1.09–2.74, P = 0.020) and MACEs (adjusted HR: 2.25, 95% CI: 1.19–4.25, P = 0.013). The risk of MACEs increased when the multivariable model with the score (≥ 10) plus 5-day HPR was used (adjusted HR: 4.37, 95% CI: 1.90–10.10, P = 0.001). The c-statistic for MACEs was 0.60 when using the score threshold of ≥ 10 and 0.63 when using the model with the score plus 5-day HPR. As a simple tool, the ABCD-GENE score could identify clopidogrel-treated Chinese patients with ACS who are at increased risk of MACEs. The addition of 5-day HPR could slightly improve the diagnostic ability of the score. Graphical abstract


  • Open Access

    Baseline Ratio of Soluble Fas/FasL Predicts Onset of Pulmonary Hypertension in Elder Patients Undergoing Maintenance Hemodialysis: A Prospective Cohort Study

    by Xiao-Han Ding, Xiaoliang Chai, Jin Zheng, Hong Chang, Wenxue Zheng, Shi-Zhu Bian, Ping Ye

    Background: Pulmonary hypertension (PH) is one of the most common complications associated with end-stage renal disease (ESRD). Though numerous risk factors have been founded, other risk factors remain unidentified, particularly in patients undergoing maintenance hemodialysis with elder age. Soluble Fas (sFas) and its ligand FasL (sFasL) have been reported in chronic renal disease patients; however, they have not been identified in the PH patients of elder hemodialysis patients. We aimed to determine the roles of sFas/sFasL in onset of PH in elder patients undergoing maintenance hemodialysis with ESRD.Methods: Altogether, 163 patients aged 68.00 ± 10.51 years with ESRD who undergoing maintenance hemodialysis in a prospective cohort and were followed-up for a median of 5.5 years. They underwent echocardiography examinations, liver function assessments, residual renal function, and serum ion examinations, before and after dialysis. Furthermore, levels of sFas and sFasL at baseline had also been measured. We compared demographic data, echocardiographic parameters, liver function, ions, and residual renal function as well as serum sFas and sFasL between the PH and non-PH groups. These parameters were correlated with systolic pulmonary artery pressure (sPAP) using Spearman’s correlation. Moreover, univariate and adjusted logistic regression analyses have also been conducted.Results: The incidence of PH in the elder dialysis patients was 39.1%. PH populations were demonstrated with significantly higher end-diastolic internal diameters of the left atrium, left ventricle, right ventricle (RV), and pulmonary artery, as well as the left ventricular posterior wall thickness (LVWP; all p < 0.05). A higher baseline serum sFas and sFasL levels have also been identified ( p < 0.001). They also showed lower fractional shortening and left ventricular ejection fraction (LVEF; p < 0.05). Following dialysis, the post-dialysis serum potassium concentration (K+) was significantly higher in the PH group ( p = 0.013). Furthermore, the adjusted regression identified that ratio of sFas/FasL (OR: 1.587, p = 0.004), RV (OR: 1.184, p = 0.014), LVPW (OR: 1.517, p = 0.007), and post-dialysis K+ (OR: 2.717, p = 0.040) was the independent risk factors for PH while LVEF (OR: 0.875, p = 0.040) protects patients from PH.Conclusion: The baseline ratio of sFas/sFasL, RV, LVPW, and post-dialysis K+ was independent risk factors for PH onset, while LVEF was a protective factor for PH.


  • Open Access

    Effect of Xuezhikang Therapy on Expression of Pulmonary Hypertension Related miR-638 in Patients With Low HDL-C Levels

    by Ruihua Cao, Tao Sun, Ruyi Xu, Jin Zheng, Hao Wang, Xiaona Wang, Yongyi Bai, Ping Ye

    Objective: Low plasma level of high-density lipoprotein cholesterol (HDL-C) associated with poor outcomes in several cardiovascular diseases, including pulmonary arterial hypertension (PAH). Regulation of miR-638 have been proved to be associated with PAH. The aim of this study was to evaluate the expression of miR-638 after Xuezhikang (XZK) therapy in patients with low HDL-C.Methods: Plasma levels of miR-638 were quantified by real-time polymerase chain reactions in 20 patients with PAH and 30 healthy controls. A total of 40 subjects with low HDL-C were assigned to receive an XZK therapy for 6 months. The miR-638 expression profiles were detected in PAH patients, XZK-treated subjects and lovastatin treated pulmonary arterial smooth muscle cells (PA-SMCs).Results: The relative expression level of miR-638 in the plasma was lower in the PAH patients than that in the controls (p < 0.001). An increase of 11.2% from baseline in the HDL-C level was found after XZK therapy (p < 0.001). The relative expression of miR-638 was increased after XZK treatment (p < 0.01). The changes of miR-638 were inversely associated with baseline HDL-C levels. A significantly reduction in miR-638 expression were found in PDGF-BB-treated hPA-SMCs compared to the control cells, and the pre-treatment of the cells with lovastatin significantly re-gain the expression levels in miR-638.Conclusion: In patients with low HDL-C levels, XZK therapy raised the expression of miR-638, suggesting that the potential therapeutic effect of XZK in PAH patients with low serum HDL-C levels deserves further exploration.


  • Functions of Monocytes and Macrophages and the Associated Effective Molecules and Mechanisms at the Early Stage of Atherosclerosis

    by Liyuan Jin, Zihui Deng, Yongyi Bai, Ping Ye

    Objective: This study aimed to explore the functions and possible underlying regulatory molecules and mechanisms of monocytes and macrophages under early atherosclerotic conditions. Methods: THP-1-derived monocytes or macrophages were induced by 50 g/ml oxidized low density lipoprotein (ox-LDL) for 24 hours, and the degree of lipid metabolism and inflammation were determined. In addition, we identified differentially expressed genes, noncoding ribonucleic acids (RNAs), pathways and mechanisms by RNA sequencing, and performed further correlation analysis and molecular expression verification. Results: Monocytes could not form foam cells with oil red 0 staining directly and had low levels of lipids as determined by total cholesterol and triglycerides assays, cholesterol uptake molecules CD36, the class A macrophage scavenger receptor and lectin-like oxidized low-density lipoprotein receptor-1 and cholesterol efflux molecules ATP binding cassette transporter Al, ATP binding cassette transporter G1 and liver X receptor a, and inflammatory factors, which were markedly different from those in macrophages. Additionally, sequencing data showed obviously differentially expressed genes, microRNAs and long noncoding RNAs in the atherosclerotic group. We identified 15 upregulated and downregulated genes, and 10 biological processes and pathways involved in atherosclerosis. Specifically, fatty acid desaturase 2 and apolipoprotein Al in the peroxisome proliferator-activated receptor signaling pathway were differentially expressed in stimulated macrophages, whereas no changes were observed in the monocyte groups. Furthermore, correlation analysis showed differential expressed IncRNAs targeting miRNAs and mRNAs, and 24 competing endogenous RNA (ceRNA) networks of long noncoding RNA-microRNA-messenger RNA in early oxidative macrophages. Conclusions: Monocytes did not directly participate in lipid metabolism before differentiation into macrophages at the early stage in vitro. Furthermore, noncoding RNAs and ceRNA networks might play important roles in regulating the lipid metabolism of macrophages at the early stage of atherosclerosis.


  • Open Access

    High-Sensitivity Cardiac Troponin T Is a Risk Factor for Major Adverse Cardiovascular Events and All-Cause Mortality: A 9.5-Year Follow-Up Study

    by Xiaona Wang, Peiqi Wang, Ruihua Cao, Xu Yang, Wenkai Xiao, Yun Zhang, Li Sheng, Ping Ye

    Background. The relationship between high-sensitivity cardiac troponin T (hs-cTnT) and different cardiovascular events has been observed in several large community studies, and the results have been controversial. However, there is currently no cross-sectional or longitudinal follow-up study on hs-cTnT in the Chinese population. Methods. We analyzed the association of plasma hs-cTnT levels with major adverse cardiovascular events (MACEs) and all-cause mortality in 1325 subjects from a longitudinal follow-up community-based population in Beijing, China. Results. In the Cox proportional hazards models analysis, the risk of MACEs increased with the increase of hs-cTnT levels (HR, 1.223, 95% CI, 1.054–1.418, P = 0.008 ). Increased hs-cTnT levels were associated with coronary events (HR, 1.391, 95% CI, 1.106–1.749, P = 0.005 ) in Model 4. Cox proportional risk regression model analysis revealed that increased hs-cTnT levels were associated with an increased risk of mortality (HR, 1.763, 95% CI, 1.224–2.540, P = 0.002 ), even after adjusting hs-CRP and NT-proBNP. The area under the ROC curve for predicting MACEs was 0.559 (95% CI, 0.523–0.595, P = 0.001 ). The areas under the ROC curve for predicting coronary events and mortality were 0.629 (95% CI, 0.580–0.678, P < 0.001 ) and 0.644 (95% CI, 0.564–0.725, P < 0.001 ), respectively. Conclusions. Our findings in the Chinese cohort support that hs-cTnT is a risk factor for major adverse cardiovascular events and all-cause mortality.


  • Open Access

    Plasma Homocysteine Is a Predictive Factor for Accelerated Renal Function Decline and Chronic Kidney Disease in a Community-Dwelling Population

    by Wenkai Xiao, Ping Ye, Fan Wang, Ruihua Cao, Yongyi Bai, Xiaona Wang

    Background: Whether elevated plasma total homocysteine (tHcy) is a risk factor for the progression of kidney disease in general population has not been well established. The purpose of this study was to investigate the prognostic properties of plasma tHcy for renal function decrement and early chronic kidney disease (CKD) in community-dwelling populations with normal renal function at baseline. Methods: A total of 1,426 participants were enrolled and followed for a median of 4.8 years (interquartile range, 4.5–5.2), and estimated glomerular filtration rate (eGFR) was evaluated. One main outcome was the rapid eGFR decline defined as a decline in eGFR of >3 mL/min per 1.73 m2 per year; the other was the new incidence of CKD. Results: At the end of follow-up, the incidence of rapid eGFR decline and new-onset CKD was 20.7 and 5.6%, respectively. In multivariate linear regression analysis, age, central pulse pressure, fasting blood glucose, and concentration of tHcy were independent determinants of the change in eGFR. There was a graded association between tHcy quartiles and eGFR decline. Compared with participants with the lowest quartile of tHcy levels, those with the highest quartile had significantly increased risk for rapid eGFR decline (adjusted odds ratio [aOR] = 1.81; 95% confidence interval [CI]: 1.25–2.94) and new onset of CKD (adjusted hazard ratio = 4.29; 95% CI: 1.42–12.99) after adjusting for various confounders. Similarly, significant associations were also found when baseline tHcy was classified as hyperhomocysteinemia (>15 μmol/L) versus normal tHcy level (≤15 μmol/L). However, there was only association between the change in tHcy levels and new occurrence of CKD but not with rapid eGFR decline (aOR = 0.99, p = 0.613). Conclusions: In this prospective cohort of individuals from community-based population, elevated plasma tHcy emerged as an independent predictor of renal function decline and incident CKD, which might support selection of at-risk individuals.


  • Open Access

    Valor Prognóstico dos Níveis Plasmáticos de NT-proBNP em Pacientes Hospitalizados com Mais de 80 Anos de Idade em um Hospital em Pequim, China

    by Qiwei Zhu, Peng Gao, Shihui Fu, Hao Wang, Yongyi Bai, Leiming Luo, Ping Ye

    Resumo Fundamento Apesar das evidências crescentes de que o peptídeo natriurético N-terminal pró-cérebro (NT-proBNP) tem um valor prognóstico importante em adultos mais velhos, há dados limitados sobre seu valor preditivo prognóstico. Objetivos O objetivo deste estudo é avaliar o significado clínico do NT-proBNP em pacientes hospitalizados com mais de 80 anos de idade em Pequim, China. Métodos Este estudo prospectivo e observacional foi conduzido em 724 pacientes muito idosos em uma enfermaria geriátrica (idade ≥80 anos, variação, 80-100 anos, média, [...] Resumo Fundamento Apesar das evidências crescentes de que o peptídeo natriurético N-terminal pró-cérebro (NT-proBNP) tem um valor prognóstico importante em adultos mais velhos, há dados limitados sobre seu valor preditivo prognóstico. Objetivos O objetivo deste estudo é avaliar o significado clínico do NT-proBNP em pacientes hospitalizados com mais de 80 anos de idade em Pequim, China. Métodos Este estudo prospectivo e observacional foi conduzido em 724 pacientes muito idosos em uma enfermaria geriátrica (idade ≥80 anos, variação, 80-100 anos, média,


  • Open Access

    Correlation between small and dense low‐density lipoprotein cholesterol and cardiovascular events in Beijing community population

    by Xiaona Wang, Liang Wang, Ruihua Cao, Xu Yang, Wenkai Xiao, Yun Zhang, Ping Ye

    The relationship between small dense low‐density lipoprotein cholesterol (sdLDL‐C) and different cardiovascular events has been observed in several large community studies, and the results have been controversial. However, there is currently no cross‐sectional or longitudinal follow‐up study on sdLDL‐C in the Chinese hypertension population. We analyzed the association of plasma sdLDL‐C levels with major adverse cardiovascular events in 1325 subjects from a longitudinal follow‐up community‐based population in Beijing, China. During the follow‐up period, a total of 191 subjects had MACEs. Cox regression analysis showed that sdLDL‐C is a major risk factor for MACEs independent of sex, age, BMI, hypertension, diabetes, smoking, SBP, DBP, FBG, eGFR in the general community population (1.013 (1.001 −1.025, P < .05)), but the correlation disappeared after adjusting for TC and HDL‐C in Model 3. Cox analysis showed that hypertension combined with high level of sdLDL‐C was still the risk factor for MACEs ((2.079 (1.039‐4.148)). Our findings in the Chinese cohort support that sdLDL‐C is a risk factor for major adverse cardiovascular events in hypertension subjects.


  • Open Access

    The Mechanisms of miR-638/StarD10 in HDL Metabolism

    by Ping Ye, Xiaona Wang, Jie Han, Ruihua Cao, Yongyi Bai

    Background: MicroRNA (miRNA) plays an important role in regulation of genes, especially in post-transcriptional level. Many studies had studied the role of miRNAs in the development and progression of cardiovascular disease through miRNA knockout mice models, and chemically synthesized mimics or inhibitors of miRNAs. This study was designed to further investigate the effect of miR-638 on lipid metabolism-related gene expression.Methods: miR-638 mimics and inhibitors were transfected into HepG2 and macrophages. Appropriate concentrations and time points used to treat cells were determined through pre-experiment. Then RT2 Profiler™ PCR Array chips contained 84 human lipoprotein signals and cholesterol metabolism related gene were used to investigate the effect of miR-638 on lipid metabolism. Real-time PCR and Western blot were also used to verify the results. Mice received 2 times tail vein injections of StarD10 mimics and inhibitors the first week, and the injection continued three weeks with one time foreach week. Total plasma cholesterol, triglyceride, LDL-C and HDL-C levels were obtained at sacrifice; All mice were injected intraperitoneally with H3-cholesterol–labeled and cholesterol -loaded raw 264.7 macrophages (0.5m L /mice). Serum, liver tissues and feces were collected at 24 hour. All samples were analyzed for the appearance of 3H-tracer (as the percentage of the total injected counts). Protein were extracted from liver tissue, and Western-blot was conducted to evaluate lipid metabolism related protein expression. Sacrificed the mice and removed the aortas, aorta plaque and macrophage were investigated by examination of stained sections by H-E staining, Oil-red O staining and CD68+ staining.Results: Transfected miR-638 Mimics in HepG2 cells and macrophages could significantly increase the expression of miR-638. Transfected miR-638 Inhibitors in HepG2 cells could significantly decreased the expression of miR-638. Results showed that transfected miR-638 Mimics in HepG2 cells and macrophages could reduce the RNA and protein expression levels of ATP-binding cassette A-1 (ABCA1), ATP-binding cassette G-1 (ABCG1) and very low density lipoprotein receptor (VLDLR), and transfected miR-638 Inhibitors in HepG2 cells could increase the RNA and protein expression levels of ABCA1 and ABCG1. Compared with the control groups, the levels of LDL-C and TC were decreased lightly, while the level of HDL3-C/HDL-C was increased in the StarD10 mimics group. The amount of 3H-cholesteral in StarD10 mimics group were increased by 62.86% in the plasma, 30.73% in the liver and 52.72% in the feces, respectively. The expression of ABCA1, ABCG1, protein in the liver was higher in StarD10 mimics. The ratio of the plaque area to luminal area of mice in the StarD10 mimics group is slighter smaller than that of the adenovirus control group, but there is no statistical difference (P > 0.05). Compared with mice in the adenovirus control group, mice in the StarD10 mimics group have much lower lipid content (P < 0.01) and macrophage content (P < 0.01) in the plaque. Conclusions: MiR-638/StarD10 could influence the expression levels of genes related to lipid metabolism. MiR-638/StarD10 can influence the blood lipid level, promote reverse transport of cholesterol, and StarD10 can reduce macrophage content and lipid content in the active surface patches in the mice.